Pharma Audits 2025 Introduction: Pharmaceutical companies face a growing wave of unannounced audits and stricter global regulations. From the USFDA and EMA to CDSCO and WHO , every authority now expects not just compliance—but continuous inspection readiness . In 2025, being “audit-ready” means maintaining real-time control, transparent data, and validated systems —not scrambling when an inspection notice arrives. Why Audit Readiness Matters Audit readiness is no longer a
